Back to search results

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced/Metastatic Solid Tumors · Bladder Cancer · Urothelial Carcinoma · Advanced Non-Small Cell Lung Cancer · Carcinoma, Non Small Cell Lung · Carcinoma, Squamous Cell of Head and Neck · Head and Neck Cancer · Esophageal Cancer · Gastroesophageal Junction Adenocarcinoma · Esophageal Squamous Cell Carcinoma · Esophageal Adenocarcinoma · Pancreatic Adenocarcinoma · Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope National Medical Center, Duarte, California, United States

  • City of Hope at Irvine Lennar, Irvine, California, United States

  • Ronald Reagan UCLA Medical Center, Los Angeles, California, United States

  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles, California, United States

  • Santa Monica UCLA Medical Center & Orthopaedic Hospital, Santa Monica, California, United States

  • UCLA Hematology/Oncology - Santa Monica, Santa Monica, California, United States

  • Smilow Cancer Hospital - Yale New Haven Health, New Haven, Connecticut, United States

  • Yale - New Haven Hospital - Yale Cancer Center, New Haven, Connecticut, United States

  • Smilow Cancer Hospital Phase 1 Unit, New Haven, Connecticut, United States

  • Smilow Cancer Hospital - Trumbull, Trumbull, Connecticut, United States

  • Brigham and Women's Hospital, Boston, Massachusetts, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • Dana-Farber Cancer Institute - Chestnut Hill, Newton, Massachusetts, United States

  • Sarah Cannon Research Institute - Pharmacy, Nashville, Tennessee, United States

  • SCRI Oncology Partners, Nashville, Tennessee, United States

  • The University of Texas MD Anderson Cancer Center - Conroe, Conroe, Texas, United States

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston, Texas, United States

  • The University of Texas, MD Anderson Cancer Center - League City, League City, Texas, United States

  • NEXT Oncology, San Antonio, Texas, United States

  • The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land, Texas, United States

  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

  • Pan American Center for Oncology Trials, LLC, Rio Piedras, Puerto Rico

  • Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [barcelona], Spain

  • Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad de, Spain

  • Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

  • Barts Cancer Centre at St. Bartholomew's Hospital; Queen Mary University of London, London, United Kingdom

  • The Christie NHS Foundation Trust, Manchester, United Kingdom

Study leads

  • Pfizer CT.gov Call Center

    Study Director

    Pfizer

View source on ClinicalTrials.gov(opens in a new tab)